Global Oncolytic Virus Therapy

Global Oncolytic Virus Therapy Market Research Report: Forecast (2022-2027)

Therapy (IMLYGIC (Talimogene Laherparepvec), Oncorine, RIGVIR Immunotherapy, Onyx-15, and Reolysin), By Application (Solid Tumor (Breast Cancer, Prostate Cancer, Lung Cancer, Glioblastoma/Glioblastoma Read more

  • Healthcare
  • Nov 2021
  • 221
  • HC22075

Oncolytic Viruses (OVs) are genetically engineered or naturally occurring viruses that selectively target & kill cancer cells without harming the normal tissues. This therapy is a new therapeutic procedure to treat cancer patients and has presented promising outcomes worldwide.

According to MarkNtel Advisors, the Global Oncolytic Virus Therapy Market is projected to grow at a CAGR of around 20.3% during the forecast period i.e. 2022-27. The market is driven primarily by the mounting prevalence of cancer worldwide and the surging number of clinical trials & R&D investments for cancer therapies.

Moreover, the burgeoning focus of the governments in both developed & emerging countries on reducing mortality & morbidity rates by conducting various awareness campaigns toward encouraging people to opt for early diagnosis has increased the patient pool of oncolytic virus therapies. Hence, in the coming years, the global market is projected to significantly grow and create lucrative growth opportunities for the leading players in the market.

Report Coverage Details
Study Period Historical Data: 2017-20
Base Year: 2021
Forecast Period: 2022-27
CAGR 20.3%
Regions Covered North America: USA, Canada, Mexico
Europe: Germany, UK, France, Italy, Spain
Asia-Pacific: China, India, Japan, Australia
South America: Brazil, and Argentina
Middle East & Africa:  UAE, Saudi Arabia, South Africa
Key Companies Profiled Amgen Inc., Daiichi Sankyo Company Limited, DNAtrix, Genelux Corporation, Oncolytics Biotech Inc., PsiOxus Therapeutics, RIGVIR Ltd., Shanghai Sunway Biotech Co. Ltd., SillaJen Inc., Sorrento Therapeutics Inc., Takara Bio Inc., Lokon Pharma AB, VCN Biosciences, ViroCure Inc., Viralytics Ltd. (Merck & Co. Inc.)
Unit Denominations USD Million/Billion

 

Impact of Covid-19 on the Global Oncolytic Virus Therapy Market

  • The Covid-19 pandemic in 2020 brought the entire healthcare sector under extensive pressure.
  • It made many nations realize that their healthcare infrastructure wasn't prepared or sufficient enough to handle such a large influx of very sick Covid-19 patients.
  • Overcrowded emergency rooms, which were initially feared, turned into reality across many communities.
  • However, the mounting need for an effective vaccine against the coronavirus and continued R&D on using Oncolytic Virus therapies to fight the Covid-19 infection helped the market remain steady amidst the crisis.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
    4. Market Segmentation
  2. Executive Summary
  3. Impact of Covid-19 on Oncolytic Virus Therapy Market
  4. Global Oncolytic Virus Therapy Market Policies & Regulations
  5. Global Oncolytic Virus Therapy Market Trends & Insight
  6. Global Oncolytic Virus Therapy Market Dynamics
    1. Impact Analysis
    2. Drivers
    3. Challenges
  7. Global Oncolytic Virus Therapy Market Hotspot & Opportunities
  8. Global Oncolytic Virus Therapy Market Analysis, 2018-2027
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapy
        1. IMLYGIC (Talimogene Laherparepvec)
        2. Oncorine
        3. RIGVIR Immunotherapy
        4. Onyx-15
        5. Reolysin
      2. By Application
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma/Glioblastoma Multiforme
        2. Melanoma
        3. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
      3. By Type of Virus
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus(HSV)
          2. Adenovirus
          3. Vaccinia Virus
        2. Oncolytic Wild Type of Viruses
          1. Myxoma
          2. Vesicular Stomatitis Virus (VSV)
          3. Newcastle Disease Virus (NDV)
          4. Reovirus (Respiratory Enteric Orphan Virus)
      4. By End-User
        1. Hospitals
        2. Clinics
        3. Patients
        4. Cancer Research Institutes
      5. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia Pacific
      6. By Company
        1. Revenue Shares
        2. Strategic Factorial Indexing
        3. Competitor Placement in MarkNtel Quadrant
  1. North America Oncolytic Virus Therapy Market Outlook, 2018-2027
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapy
      2. By Application
      3. By Type of Virus
      4. By End-User
      5. By Country
        1. US
        2. Canada
        3. Mexico
        4. Others
    3. US Oncolytic Virus Therapy Market Outlook, 2018-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    4. Canada Oncolytic Virus Therapy Market Outlook, 2018-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Application
        2. By End-User
  2. South America Oncolytic Virus Therapy Market Outlook, 2018-2027
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapy
      2. By Application
      3. By Type of Virus
      4. By End-User
      5. By Country 
        1. Brazil
        2. Argentina
        3. Others
  3. Europe Oncolytic Virus Therapy Market Outlook, 2018-2027
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapy
      2. By Application
      3. By Type of Virus
      4. By End-User
      5. By Country
        1. UK
        2. Germany
        3. France
        4. Italy
        5. Spain
        6. Others
    3.  The UK Oncolytic Virus Therapy Market Outlook, 2018-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    4.  Germany Oncolytic Virus Therapy Market Outlook, 2018-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    5.  France Oncolytic Virus Therapy Market Outlook, 2018-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    6.  Italy Oncolytic Virus Therapy Market Outlook, 2018-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    7.  Spain Oncolytic Virus Therapy Market Outlook, 2018-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Application
        2. By End-User
  4.  Middle East & Africa Oncolytic Virus Therapy Market Outlook, 2018-2027
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapy
      2. By Application
      3. By Type of Virus
      4. By End-User
      5. By Country 
        1. UAE
        2. Saudi Arabia
        3. South Africa
        4. Others
  5. Asia Pacific Oncolytic Virus Therapy Market Outlook, 2018-2027
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapy
      2. By Application
      3. By Type of Virus
      4. By End-User
      5. By Country
        1. India
        2. China
        3. Japan
        4. Australia
        5. Others
    3.  India Oncolytic Virus Therapy Market Outlook, 2018-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    4.  China Oncolytic Virus Therapy Market Outlook, 2018-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    5.  Japan Oncolytic Virus Therapy Market Outlook, 2018-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    6. Australia Oncolytic Virus Therapy Market Outlook, 2018-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Application
        2. By End-User
  6. Competitive Benchmarking
    1. Competition Matrix
      1. Product Portfolio
      2. Target Market
      3. Research & Development
      4. Strategic Initiatives
  7. Company Profile
    1. Amgen Inc.
    2. Daiichi Sankyo Company Limited
    3. DNAtrix
    4. Genelux Corporation
    5. Oncolytics Biotech Inc.
    6. PsiOxus Therapeutics
    7. RIGVIR Ltd.
    8. Shanghai Sunway Biotech Co. Ltd.
    9. SillaJen Inc.
    10. Sorrento Therapeutics Inc.
    11. Takara Bio Inc.
    12. Lokon Pharma AB
    13. VCN Biosciences
    14. ViroCure Inc.
    15. Viralytics Ltd. (Merck & Co. Inc.)
  8. Disclaimer
Oncolytic Virus Therapy Market Segmentation
*This field is required